Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study.

Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer

gemcitabine - Generic mfg.

Keytruda (pembrolizumab) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42727307

Aram Babcock; Blanca Homet Moreno; Chethan Ramamurthy; Ernesto Ulloa-Pérez; Haojie Li; Melanie Mayer; Nicholas J Seewald; Ronac Mamtani

Sep 12, 2026